Results 271 to 280 of about 64,446 (303)
Some of the next articles are maybe not open access.
Direct Oral Anticoagulants in Cancer Patients
Seminars in Thrombosis and Hemostasis, 2019AbstractCancer-associated thrombosis (CAT) is a common occurrence in the journey of a cancer patient and its management poses significant challenges. Low molecular weight heparin (LMWH) is the standard of care but the high cost and the inconvenience of daily injections have led to low persistence with therapy.
Deepa, Suryanarayan +2 more
openaire +2 more sources
Direct oral anticoagulants in trauma patients
Current Opinion in AnaesthesiologyPurpose of review Direct oral anticoagulants (DOACs) are increasingly prescribed for prevention of thromboembolic events. Thus, trauma care providers are facing a steadily raising number of injured patients on DOACs. Recent findings Despite a predictable pharmacokinetic profile, the
Herbert, Schöchl +2 more
openaire +2 more sources
Direct Oral Anticoagulants: Monitoring Anticoagulant Effect.
Hematology/oncology clinics of North America, 2017In some clinical settings laboratory measurement of direct oral anticoagulants effect is helpful in guiding medical care, such as life-threatening bleeding, need for emergency surgery, renal impairment, severe hepatic failure, extremes of body weight, or in patients with bleeding or thrombosis on therapy.
openaire +1 more source
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly
Health insurance status and cancer stage at diagnosis and survival in the United States
Ca-A Cancer Journal for Clinicians, 2022Jingxuan Zhao +2 more
exaly
Direct oral anticoagulant drugs (DOAC)
Journal of Cataract and Refractive Surgery, 2016Robert A, Blum, Dan, Lindfield
openaire +2 more sources